B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Bozhi,Shen

第一单位： The First Clinical Medicine College, Nanjing Medical University, Nanjing 211166, China; The Laboratory Center for Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China.

作者： Bozhi,Shen ^[1] ; Jie,Mei ^[2] ; Rui,Xu ^[2] ; Yun,Cai ^[3] ; Mengyun,Wan ^[4] ; Ji,Zhou ^[4] ; Junli,Ding ^[5] ; Yichao,Zhu ^[6]

作者单位： The First Clinical Medicine College, Nanjing Medical University, Nanjing 211166, China; The Laboratory Center for Basic Medical Sciences, Nanjing Medical University, Nanjing 211166, China. ^[1] The First Clinical Medicine College, Nanjing Medical University, Nanjing 211166, China. ^[2] Department of Laboratory Medicine, Changzhou Jintan First People's Hospital, Changzhou 213200, China. ^[3] Department of Physiology, Nanjing Medical University, Nanjing 211166, China. ^[4] Department of Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China. Electronic address: dingjunliletters@163.com. ^[5] Department of Physiology, Nanjing Medical University, Nanjing 211166, China. Electronic address: zhuyichao@njmu.edu.cn. ^[6]

关键词 B7-H3 Biomarker Immunotherapy Melanoma Tumor microenvironment

主题词人类(Humans);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);黑色素瘤(Melanoma);表型(Phenotype);肿瘤微环境(Tumor Microenvironment)

DOI 10.1016/j.prp.2024.155267

PMID 38520953

发布时间 2024-04-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交